Nature Communications (May 2022)
Off-season RSV epidemics in Australia after easing of COVID-19 restrictions
- John-Sebastian Eden,
- Chisha Sikazwe,
- Ruopeng Xie,
- Yi-Mo Deng,
- Sheena G. Sullivan,
- Alice Michie,
- Avram Levy,
- Elena Cutmore,
- Christopher C. Blyth,
- Philip N. Britton,
- Nigel Crawford,
- Xiaomin Dong,
- Dominic E. Dwyer,
- Kimberly M. Edwards,
- Bethany A. Horsburgh,
- David Foley,
- Karina Kennedy,
- Cara Minney-Smith,
- David Speers,
- Rachel L. Tulloch,
- Edward C. Holmes,
- Vijaykrishna Dhanasekaran,
- David W. Smith,
- Jen Kok,
- Ian G. Barr,
- the Australian RSV study group
Affiliations
- John-Sebastian Eden
- Centre for Virus Research, Westmead Institute for Medical Research
- Chisha Sikazwe
- PathWest Laboratory Medicine WA, Department of Microbiology
- Ruopeng Xie
- School of Public Health, LKS Faculty of Medicine, The University of Hong Kong
- Yi-Mo Deng
- WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity
- Sheena G. Sullivan
- WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity
- Alice Michie
- School of Biomedical Sciences, The University of Western Australia
- Avram Levy
- PathWest Laboratory Medicine WA, Department of Microbiology
- Elena Cutmore
- Centre for Virus Research, Westmead Institute for Medical Research
- Christopher C. Blyth
- PathWest Laboratory Medicine WA, Department of Microbiology
- Philip N. Britton
- Sydney Institute for Infectious Diseases, Sydney Medical School, The University of Sydney
- Nigel Crawford
- Murdoch Children’s Research Institute
- Xiaomin Dong
- WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity
- Dominic E. Dwyer
- Sydney Institute for Infectious Diseases, Sydney Medical School, The University of Sydney
- Kimberly M. Edwards
- School of Public Health, LKS Faculty of Medicine, The University of Hong Kong
- Bethany A. Horsburgh
- Centre for Virus Research, Westmead Institute for Medical Research
- David Foley
- PathWest Laboratory Medicine WA, Department of Microbiology
- Karina Kennedy
- Departments of Clinical Microbiology and Infectious Diseases, Canberra Hospital
- Cara Minney-Smith
- PathWest Laboratory Medicine WA, Department of Microbiology
- David Speers
- PathWest Laboratory Medicine WA, Department of Microbiology
- Rachel L. Tulloch
- Centre for Virus Research, Westmead Institute for Medical Research
- Edward C. Holmes
- Sydney Institute for Infectious Diseases, Sydney Medical School, The University of Sydney
- Vijaykrishna Dhanasekaran
- School of Public Health, LKS Faculty of Medicine, The University of Hong Kong
- David W. Smith
- PathWest Laboratory Medicine WA, Department of Microbiology
- Jen Kok
- NSW Health Pathology - Institute for Clinical Pathology and Medical Research, Westmead Hospital
- Ian G. Barr
- WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity
- the Australian RSV study group
- DOI
- https://doi.org/10.1038/s41467-022-30485-3
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 9
Abstract
Non-pharmaceutical interventions for COVID-19 also reduced incidence of respiratory pathogens such as respiratory syncytial virus (RSV). Here, the authors report the resurgence of RSV in Australia following lifting of some of the restrictions and describe reduction in genetic diversity in circulating clades.
